STOCKHOLM, Feb. 27, 2020 /PRNewswire/ -- Hygiene and health company Essity has signed an agreement to acquire 75% of the Swedish medical solutions company ABIGO Medical AB. The company as a whole is valued at SEK 900m on a debt-free basis. ABIGO Medical AB develops, manufactures and markets products including the Sorbact® t

SAN FRANCISCO, Feb. 27, 2020 /PRNewswire/ --  Qure.ai (www.qure.ai), a leading healthcare AI startup, has announced that they have raised $16M in a funding round led by Sequoia India and supported by MassMutual Ventures Southeast Asia (SEA). Qure.ai will use this new capit

-  Submission based on data from the Phase III PRIMA clinical study that demonstrated clinically meaningful outcomes of niraparib maintenance treatment in the first-line setting regardless of biomarker status LONDON, Feb. 27, 2020 /PRNewswire/ -- GlaxoSmithKline plc announced that the European Medicines Agency (EMA) has validated the

SHANGHAI, Feb. 27, 2020 /PRNewswire/ -- WuXi Diagnostics has successfully developed a series of COVID-19 detection products, including 2019-nCoV IgM Detection kit (Enzyme-linked Immunoassay, ELISA), 2019-nCoV IgM/IgG Detection Kit (Enzyme-linked Immunoassay, ELISA) and 2019-nCoV Nucleic Acid Detection Kit (PCR-Fluorescent Probe Method)

SAN DIEGO, Feb. 26, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA) announced today the pricing of its offering of $450,000,000 aggregate principal amount of 0.375% Convertible Senior Notes due 2025 (the "Convertible Notes") in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as

STOCKHOLM, Feb. 27, 2020 /PRNewswire/ -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the company is donating the medical device AnaConDa and accessories for anti-epidemic use and evaluation of the effects of inhalation sedation with AnaConDa on severely ill Corona virus affected patients to two hospitals in Wuhan

LONDON, Feb. 27, 2020 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma, Group), the multinational generic pharmaceutical company, and Glenmark Specialty S.A., a Swiss subsidiary of Glenmark Pharmaceuticals, a global innovative pharmaceutical company, today announce the signing of an exclusive US license agreement to commercialise Ryaltris™ (olopatadi

ÖSTERSUND, Sweden, Feb. 27, 2020 /PRNewswire/ -- Skanska has signed a contract with Oulu University Hospital to build a new hospital building in Oulu, Finland. Skanska's share of the contract is worth EUR 190 M, about SEK 2.0 billion, which will be included in the Nordic

LUND, Sweden, Feb. 27, 2020 /PRNewswire/ -- "We are proud that we have delivered on our goals for the year and feel confident that we will continue to do so in 2020, with a number of important milestones approaching. Our cooperation with Merck & Co is our second large pharma collaboration and an excellent validation of BioInvent's work, as we develop BI-1206 in so

OSLO, Norway, Feb. 27, 2020 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) announces its results for the fourth quarter and full year 2019. A presentation by the company's senior management team will take place today in Oslo at 08:30 CET, see details below.Jan H. Egberts, MD, Chairman of Nordic N